We're here for you

Guillain-Barré and Associated Inflammatory Neuropathies (GAIN) provide information and support for anyone affected by GBS, CIDP, Miller Fisher, MMN, and other related inflammatory neuropathies.

It's GBS and CIDP Awareness Month in May

Join us in raising awareness and sharing experiences of GBS and CIDP through events, webinars, and discussion

Take the GAINmomentum Challenge this May

GAINmomentum is all about being active, promoting physical and emotional wellbeing, and raising awareness of GBS, CIDP, and other associated inflammatory neuropathies.

Guillain-Barré & Associated Inflammatory Neuropathies

Information

Information Hub

Our easy to use platform will give you the answers and advice you need

Support

Ways we can help patients and their families

In your own words

Inspirational stories and videos

How can we help?

Get in touch

Phone, email. use contact us

Downloads

Useful information guides you can download for free

Video Chat

Join our on-line community

Get Involved

Fundraising

Help us to raise funds and support GAIN

Volunteer

Help us to help others at this difficult time

Research

GAIN Funded Research

Our easy to use platform will give you the answers and advice you need

News

Recently published news & information

Support Us

Donate – Fundraising

Make a one off donation, start fundraising, or pay money direct to us

Shop

Buy GAIN products from our online shop

Leave GAIN a gift

Free Will writing service

200 Club

Join the 200 lottery today

News

We have a new CEO

Monday 22nd January 2024 GAIN have appointed Rich Collins to the role of CEO. Rich’s background is in community sector leadership, strategy, and social policy. He has previously been a Chief Executive in a not for profit organisation, but also has significant...

read more

Treatment Approaches for Atypical CIDP

The variants of chronic inflammatory demyelinating polyneuropathy (CIDP) differ not just in their clinical, pathological and electrophysiological characteristics, but often in their indifferent response to conventional immunosuppressive agents which are effective in...

read more